2024 Ipo Market In Biotech

2024 Ipo Market In Biotech. The developer of cell therapies for autoimmune diseases launched its ipo with shares priced $22 a piece and is now trading around $29 per share as of market. In biotech, companies typically go public to raise large sums to develop their assets.


2024 Ipo Market In Biotech

Ipo tracker life sciences companies face unique issues in accessing capital markets, including matters related to due diligence, public relations, regulatory and intellectual. Coming off a terrible year for ipos, two new upsized public offerings provide a stretching ray of hope for 2024.

2024 Ipo Market In Biotech Images References :